Pediatrix Medical Group vs Natera
Natera reported revenue of $2.3 billion in fiscal 2025, 1.2 times Pediatrix Medical Group's $1.9 billion in fiscal 2025. Pediatrix Medical Group's revenue fell 4.9% in its latest year, and Natera's grew 35.9%. Pediatrix Medical Group had an operating margin of 10.9%, against -13.4% at Natera. Free cash flow was $253 million at Pediatrix Medical Group and $109 million at Natera.
Side by side
| Pediatrix Medical Group | Natera | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $1.9B | $2.3B |
| Revenue growth | −4.9% | 35.9% |
| Revenue growth a year, last 5 years | 2.0% | 42.6% |
| Gross margin | — | — |
| Operating margin | 10.9% | −13.4% |
| Net margin | 8.6% | −9.0% |
| Free cash flow | $253M | $109M |
| Free cash flow margin | 13.2% | 4.7% |
| Return on capital | 16.0% | — |
| Net debt to EBITDA | 0.4x | — |
| Dividends and buybacks | $87M | $0M |
| Change in diluted share count | 2.3% | 9.6% |
| Last close | $31.29 | $310.67 |
| P/E at the last close | 17.0× | — |
| Insider trades, last 12 months | sold $1.6 million | sold $340.5 million |
| Piotroski F-score | 6 of 8 | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Pediatrix Medical GroupNatera
Operating margin
Percent of revenue
Pediatrix Medical GroupNatera
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Pediatrix Medical GroupNatera
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Pediatrix Medical Group and Natera pages.